Literature DB >> 6336186

Genetic epidemiology of coeliac disease.

J L Tiwari, H Betuel, L Gebuhrer, N E Morton.   

Abstract

Segregation analysis favors a gene additive on liability with a frequency of 0.022, which is nearly recessive on the penetrance scale. Less than one-eighth of DR3 and DR7 haplotypes carry a determinant for coeliac disease. There is significant excess of DR3/7 heterozygotes among patients, indicating that the determinants are qualitatively different in DR3 and DR7 haplotypes. Linkage to HLA is highly significant (maximum lod score = 10.9). Evidence for recombination of 8% in males is attributed to residual errors in the model. We suggest an approach to a more precise model.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6336186     DOI: 10.1002/gepi.1370010106

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  3 in total

1.  Assessing the role of HLA-linked and unlinked determinants of disease.

Authors:  N Risch
Journal:  Am J Hum Genet       Date:  1987-01       Impact factor: 11.025

2.  A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma.

Authors:  Xiangqing Sun; Jaime Vengoechea; Robert Elston; Yanwen Chen; Christopher I Amos; Georgina Armstrong; Jonine L Bernstein; Elizabeth Claus; Faith Davis; Richard S Houlston; Dora Il'yasova; Robert B Jenkins; Christoffer Johansen; Rose Lai; Ching C Lau; Yanhong Liu; Bridget J McCarthy; Sara H Olson; Siegal Sadetzki; Joellen Schildkraut; Sanjay Shete; Robert Yu; Nicholas A Vick; Ryan Merrell; Margaret Wrensch; Ping Yang; Beatrice Melin; Melissa L Bondy; Jill S Barnholtz-Sloan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-09-07       Impact factor: 4.254

3.  HLA antigens in Japanese patients with myasthenia gravis.

Authors:  K Matsuki; T Juji; K Tokunaga; M Takamizawa; H Maeda; M Soda; Y Nomura; M Segawa
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.